NK-010

N/A

Report date: 2025/07/29 20:00:11

Base Information

Drug NameNK-010
Drug Alias NameNK-010NK010
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionNatural killer cell replacements
TargetsUpdating
Therapy Area/IndicationsSolid tumoursLupus Erythematosus, SystemicLupus Nephritis +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai NK CellTech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai NK CellTech Co LtdGuangdong Provincial People'S Hospital
Inactive CompaniesN/A
Active IndicationsSolid tumoursLupus Erythematosus, SystemicLupus Nephritis +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A